SCHEMBL3987973

SCHEMBL3987973

CO[Si](CCCN(C)C)(OC)OCCO

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.34
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4751094 0.96 MAPT (0.34) MAPTALDH1A1TSHR
SCHEMBL3985269 0.84 ALDH1A1 (0.33) MAPTALDH1A1TSHR
SCHEMBL4753098 0.84 ALDH1A1 (0.33) MAPTALDH1A1TSHR
SCHEMBL27674 0.80 ALDH1A1 (0.43) ALDH1A1TSHR
SCHEMBL23554490 0.79 ALDH1A1 (0.35) ALDH1A1TSHR
Bromide SCHEMBL7778868 0.78 ALDH1A1 (0.41) ALDH1A1TSHR
Iodide SCHEMBL26983162 0.78 ALDH1A1 (0.41) ALDH1A1TSHR
Hydrochloric Acid SCHEMBL1969451 0.78 ALDH1A1 (0.41) ALDH1A1TSHR
SCHEMBL28309705 0.77 ALDH1A1 (0.33) ALDH1A1TSHR
SCHEMBL29249260 0.76 TDP1 (0.37) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008149375-A1 IMPROVED ORGANOSILICON COMPOUNDS RANKA, SEEMA, AJAY (IN) 2008-12-11 WO claimed
US-20080009644-A1 Organosilicon Compounds ZYDEX INDUSTRIES 2008-01-10 US claimed
US-7553983-B2 Organosilicon compounds ZYDEX INDUSTRIES (IN) 2009-06-30 US disclosed
WO-2008149375-A1 IMPROVED ORGANOSILICON COMPOUNDS RANKA, SEEMA, AJAY (IN) 2008-12-11 WO disclosed
US-20080009644-A1 Organosilicon Compounds ZYDEX INDUSTRIES 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009644-A1 Organosilicon Compounds CUL1, CUL3, MGAM MAPT 2267/4885ALDH1A1 1076/4885TSHR 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.